...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD8+ T-cell recall responses.
【24h】

Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD8+ T-cell recall responses.

机译:B细胞递送病毒 - 载体疫苗代表加速CD8 + T细胞召回反应的新策略。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Rapid boosting of memory CD8(+) T cells (TM) is essential in cancer immunotherapy and the control of certain infectious diseases. However, effector T cells (TE) are a barrier to booster vaccination because they can rapidly kill antigen-bearing antigen-presenting cells (APCs) before TM are engaged. We demonstrate that viral-vectored vaccines delivered by B cells elicit robust TM expansion in the presence of TE, enabling booster immunizations to bypass TE-mediated negative feedback regulation. Our data indicate that viral vector-loaded B cells home to the follicular regions in secondary lymphoid organs, which are anatomically separated from TE and in close proximity to TM. The B cells, however, do not serve as APCs in this area. Rather, classic CD11c(+) dendritic cells serve to stimulate the secondary CD8(+) T-cell response. Our data reveal that B cells represent a novel and readily accessible delivery system that can effectively engage secondary CD8(+) T-cell activation for prime-boost strategies.
机译:内存CD8(+)T细胞(TM)的快速增压对于癌症免疫疗法至关重要,并对某些传染病的控制是必不可少的。然而,效应器T细胞(TE)是加强疫苗接种的屏障,因为它们可以在TM接合之前快速杀死抗原抗原呈递细胞(APC)。我们证明,B细胞递送的病毒 - 矢量疫苗在TE存在下引发鲁棒TM膨胀,使得能够加强免疫以绕过TE介导的负反馈调节。我们的数据表明,病毒载体加载的B细胞在次级淋巴器官中的滤色区域,其与TE和近距离接近TM。然而,B细胞在该区域中不作为APC。相反,经典CD11C(+)树突细胞用于刺激次级CD8(+)T细胞反应。我们的数据显示,B细胞代表了一种新颖且易于访问的交付系统,可以有效地接合次级CD8(+)T细胞激活以进行素质 - 升压策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号